StockData
Innate Pharma SA logo

Innate Pharma SA (IPHA) stock

IPHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as IPHYF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 0/30
$1.03−0.30 (-22.56%)

Close on Nov 18, 2026Market cap $96.53MP/E –Yield –

Innate Pharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was €9.01M, down 55.2% from the year before. The highest annual figure on record is €93.95M in fiscal 2018.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025€9.01M-55.2%
FY2024Dec 31, 2024€20.12M-67.4%
FY2023Dec 31, 2023€61.64M+6.9%
FY2022Dec 31, 2022€57.67M+133.5%
FY2021Dec 31, 2021€24.70M-64.6%
FY2020Dec 31, 2020€69.77M-18.3%
FY2019Dec 31, 2019€85.45M-9.1%
FY2018Dec 31, 2018€93.95M+113.4%
FY2017Dec 31, 2017€44.03M–

More Innate Pharma figures

See a number that looks wrong?